KevinMD January 26, 2026
“Can AI scale in medicine?” is the wrong question.
The real question is: Can AI protect the soul of medicine while people who have never sat with our patients decide their fate?
The ADVOCATE program: an overview
The Trump administration recently launched the ADVOCATE program: Agentic AI-Enabled Cardiovascular Care Transformation. Run by ARPA-H, this initiative aims to build and deploy autonomous “clinical AI agents” for cardiovascular disease, with an FDA authorization pathway of roughly three years.
Three years. That is all the time we have before agentic AI systems could be embedded in our hospitals, making real-time decisions about medications, triage, and care coordination for patients with heart disease.
A physician’s perspective on AI in medicine
As a physician practicing...
Today's Sponsors
Today's Sponsor